ATE124950T1 - Nucleosid-analoge. - Google Patents

Nucleosid-analoge.

Info

Publication number
ATE124950T1
ATE124950T1 AT88905320T AT88905320T ATE124950T1 AT E124950 T1 ATE124950 T1 AT E124950T1 AT 88905320 T AT88905320 T AT 88905320T AT 88905320 T AT88905320 T AT 88905320T AT E124950 T1 ATE124950 T1 AT E124950T1
Authority
AT
Austria
Prior art keywords
nucleoside analogues
analogues
retroviral
ribofuranosyl
prophylaxis
Prior art date
Application number
AT88905320T
Other languages
English (en)
Inventor
Thomas R Webb
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE124950T1 publication Critical patent/ATE124950T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT88905320T 1987-06-05 1988-05-26 Nucleosid-analoge. ATE124950T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5830487A 1987-06-05 1987-06-05
US19027388A 1988-05-04 1988-05-04

Publications (1)

Publication Number Publication Date
ATE124950T1 true ATE124950T1 (de) 1995-07-15

Family

ID=26737474

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88905320T ATE124950T1 (de) 1987-06-05 1988-05-26 Nucleosid-analoge.

Country Status (4)

Country Link
EP (1) EP0365556B1 (de)
AT (1) ATE124950T1 (de)
DE (1) DE3854158T2 (de)
WO (1) WO1988009796A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0538194B1 (de) * 1991-10-17 1997-06-04 Novartis AG Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
US6872827B2 (en) 2002-04-26 2005-03-29 Chembridge Research Laboratories, Inc. Somatostatin analogue compounds
EP3763724A4 (de) * 2018-03-09 2022-01-12 Japan Science and Technology Agency Ss-modifizierter phosphorsäureverbindungsvorläufer, ss-modifizierte phosphorsäureverbindung, reaktionsinhibitor und medikament damit sowie reaktionshemmungsverfahren

Also Published As

Publication number Publication date
DE3854158D1 (de) 1995-08-17
WO1988009796A1 (en) 1988-12-15
EP0365556A1 (de) 1990-05-02
DE3854158T2 (de) 1996-01-18
EP0365556B1 (de) 1995-07-12

Similar Documents

Publication Publication Date Title
DK224286A (da) 2',3'-dideoxy-nucleosider
CY1889A (en) Use of 3'-azido-3'-deoxythymidine in the treatment or prophylaxis of human retroviral infections
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
DK0574457T3 (da) Antiviral nucleosidkombination
GB2204237B (en) Agents for the prophylaxis and therapy of retroviral infections
ES509706A0 (es) "mejoras introducidas en el objeto de la patente principal n 504.302".
DK441786D0 (da) Nucleosider, der kan anvendes terapeutisk
IT1224594B (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
ATE100098T1 (de) Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
FI863971A7 (fi) Farmaseuttinen koostumus käytettäväksi leukopenian hoidossa.
DK18488D0 (da) Synergistisk kombination af azelastin og theophyllin eller azelastin og beta-mimetika
IT1217446B (it) Composizione oftalmologica
GB8822546D0 (en) Antiviral combinations
ATE124950T1 (de) Nucleosid-analoge.
BR8805426A (pt) Composicao de organopolissiloxano e utilizacao da mesma
IT8621111A0 (it) Composizioni per il trattamento del le sindromi da ischemia e riperfusione
NO894658D0 (no) Antivirale forbindelser.
DE3879709D1 (de) Platin-arzneimittel.
IT1102304B (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare
IT1184687B (it) Derivato del piridone dotato di procprieta' cardiotoniche e composizioni farmaceutiche contenenti detto derivato
IT1218850B (it) Procedimento per la preaparazione di biossido di benzotiazina farmaceuticamente utilizzabile e intermedio da usare nel procedimento
RO94487A2 (ro) Compozitie pentru fabricarea frinelor cu tambur utilizate la autovehiculele grele
IT8667884A0 (it) Procedimento per la purificazione del linuron
GB8711424D0 (en) Prophylaxis & treatment of retroviral infections

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time